Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Molecular Cancer
Published in: Molecular Cancer 1/2008

Open Access 01-12-2008 | Research

Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wnt-responsive promoters to enhance beta-catenin/TCF-dependent transcription in colorectal cancer cells

Authors: Pinella Buongiorno, Vaijayanti V Pethe, George S Charames, Susmita Esufali, Bharati Bapat

Published in: Molecular Cancer | Issue 1/2008

Login to get access

Abstract

Background

β-catenin is a key mediator of the canonical Wnt pathway as it associates with members of the T-cell factor (TCF) family at Wnt-responsive promoters to drive the transcription of Wnt target genes. Recently, we showed that Rac1 GTPase synergizes with β-catenin to increase the activity of a TCF-responsive reporter. This synergy was dependent on the nuclear presence of Rac1, since inhibition of its nuclear localization effectively abolished the stimulatory effect of Rac1 on TCF-responsive reporter activity. We hypothesised that Rac1 plays a direct role in enhancing the transcription of endogenous Wnt target genes by modulating the β-catenin/TCF transcription factor complex.

Results

We employed chromatin immunoprecipitation studies to demonstrate that Rac1 associates with the β-catenin/TCF complex at Wnt-responsive promoters of target genes. This association served to facilitate transcription, since overexpression of active Rac1 augmented Wnt target gene activation, whereas depletion of endogenous Rac1 by RNA interference abrogated this effect. In addition, the Rac1-specific exchange factor, Tiam1, potentiated the stimulatory effects of Rac1 on the canonical Wnt pathway. Tiam1 promoted the formation of a complex containing Rac1 and β-catenin. Furthermore, endogenous Tiam1 associated with endogenous β-catenin, and this interaction was enhanced in response to Wnt3a stimulation. Intriguingly, Tiam1 was recruited to Wnt-responsive promoters upon Wnt3a stimulation, whereas Rac1 was tethered to TCF binding elements in a Wnt-independent manner.

Conclusion

Taken together, our results suggest that Rac1 and the Rac1-specific activator Tiam1 are components of transcriptionally active β-catenin/TCF complexes at Wnt-responsive promoters, and the presence of Rac1 and Tiam1 within these complexes serves to enhance target gene transcription. Our results demonstrate a novel functional mechanism underlying the cross-talk between Rac1 and the canonical Wnt signalling pathway.
Appendix
Available only for authorised users
Literature
1.
Ridley AJ: Rho family proteins: coordinating cell responses. Trends in cell biology. 2001, 11: 471-477. 10.1016/S0962-8924(01)02153-5CrossRef
2.
Fritz G, Just I, Kaina B: Rho GTPases are over-expressed in human tumors. International journal of cancer. 1999, 81: 682-687. 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B.CrossRef
3.
Gomez del Pulgar T, Benitah SA, Valeron PF, Espina C, Lacal JC: Rho GTPase expression in tumourigenesis: evidence for a significant link. Bioessays. 2005, 27: 602-613. 10.1002/bies.20238CrossRef
4.
Adam L, Vadlamudi RK, McCrea P, Kumar R: Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta -catenin nuclear signaling in breast cancer cells by modulating the intercellular stability. The Journal of biological chemistry. 2001, 276: 28443-28450. 10.1074/jbc.M009769200CrossRef
5.
Malliri A, Rygiel TP, Kammen van der RA, Song JY, Engers R, Hurlstone AF, Clevers H, Collard JG: The rac activator Tiam1 is a Wnt-responsive gene that modifies intestinal tumor development. The Journal of biological chemistry. 2006, 281: 543-548. 10.1074/jbc.M507582200CrossRef
6.
Liu L, Wu DH, Ding YQ: Tiam1 gene expression and its significance in colorectal carcinoma. World J Gastroenterol. 2005, 11: 705-707.PubMedCentralCrossRef
7.
Minard ME, Ellis LM, Gallick GE: Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells. Clinical & experimental metastasis. 2006, 23: 301-313. 10.1007/s10585-006-9040-zCrossRef
8.
Yeh CS, Wang JY, Wu CH, Chong IW, Chung FY, Wang YH, Yu YP, Lin SR: Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel. International journal of oncology. 2006, 28: 411-420.
9.
Benitah SA, Valeron PF, van Aelst L, Marshall CJ, Lacal JC: Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation. Biochimica et biophysica acta. 2004, 1705: 121-132.
10.
Williams CL: The polybasic region of Ras and Rho family small GTPases: a regulator of protein interactions and membrane association and a site of nuclear localization signal sequences. Cellular signalling. 2003, 15: 1071-1080. 10.1016/S0898-6568(03)00098-6CrossRef
11.
Tanaka T, Nishimura D, Wu RC, Amano M, Iso T, Kedes L, Nishida H, Kaibuchi K, Hamamori Y: Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase. The Journal of biological chemistry. 2006, 281: 15320-15329. 10.1074/jbc.M510954200CrossRef
12.
Li F, Adam L, Vadlamudi RK, Zhou H, Sen S, Chernoff J, Mandal M, Kumar R: p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells. EMBO reports. 2002, 3: 767-773. 10.1093/embo-reports/kvf157PubMedCentralCrossRef
13.
Houlard M, Arudchandran R, Regnier-Ricard F, Germani A, Gisselbrecht S, Blank U, Rivera J, Varin-Blank N: Vav1 is a component of transcriptionally active complexes. The Journal of experimental medicine. 2002, 195: 1115-1127. 10.1084/jem.20011701PubMedCentralCrossRef
14.
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science (New York, NY). 1998, 281 (5382): 1509-1512.CrossRef
15.
Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A: The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proceedings of the National Academy of Sciences of the United States of America. 1999, 96: 5522-5527. 10.1073/pnas.96.10.5522PubMedCentralCrossRef
16.
Tetsu O, McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999, 398: 422-426. 10.1038/18884CrossRef
17.
Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H: Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science . 1997, 275 (5307): 1784-1787. 10.1126/science.275.5307.1784CrossRef
18.
Brantjes H, Roose J, Wetering van De M, Clevers H: All Tcf HMG box transcription factors interact with Groucho-related co-repressors. Nucleic acids research. 2001, 29: 1410-1419. 10.1093/nar/29.7.1410PubMedCentralCrossRef
19.
Cavallo RA, Cox RT, Moline MM, Roose J, Polevoy GA, Clevers H, Peifer M, Bejsovec A: Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature. 1998, 395: 604-608. 10.1038/26982CrossRef
20.
Roose J, Molenaar M, Peterson J, Hurenkamp J, Brantjes H, Moerer P, Wetering van de M, Destree O, Clevers H: The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature. 1998, 395: 608-612. 10.1038/26989CrossRef
21.
Brannon M, Brown JD, Bates R, Kimelman D, Moon RT: XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development. Development (Cambridge, England). 1999, 126: 3159-3170.
22.
Daniels DL, Weis WI: Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nature structural & molecular biology. 2005, 12: 364-371. 10.1038/nsmb912CrossRef
23.
Thompson B, Townsley F, Rosin-Arbesfeld R, Musisi H, Bienz M: A new nuclear component of the Wnt signalling pathway. Nature cell biology. 2002, 4: 367-373. 10.1038/ncb786CrossRef
24.
Parker DS, Jemison J, Cadigan KM: Pygopus, a nuclear PHD-finger protein required for Wingless signaling in Drosophila. Development (Cambridge, England). 2002, 129: 2565-2576.
25.
Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterjee S, Murone M, Zullig S, Basler K: Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell. 2002, 109: 47-60. 10.1016/S0092-8674(02)00679-7CrossRef
26.
Hecht A, Litterst CM, Huber O, Kemler R: Functional characterization of multiple transactivating elements in beta-catenin, some of which interact with the TATA-binding protein in vitro. The Journal of biological chemistry. 1999, 274: 18017-18025. 10.1074/jbc.274.25.18017CrossRef
27.
Hecht A, Vleminckx K, Stemmler MP, van Roy F, Kemler R: The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. The EMBO journal. 2000, 19: 1839-1850. 10.1093/emboj/19.8.1839PubMedCentralCrossRef
28.
Labbe E, Letamendia A, Attisano L: Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proceedings of the National Academy of Sciences of the United States of America. 2000, 97: 8358-8363. 10.1073/pnas.150152697PubMedCentralCrossRef
29.
Kouzmenko AP, Takeyama K, Ito S, Furutani T, Sawatsubashi S, Maki A, Suzuki E, Kawasaki Y, Akiyama T, Tabata T, Kato S: Wnt/beta-catenin and estrogen signaling converge in vivo. The Journal of biological chemistry. 2004, 279: 40255-40258. 10.1074/jbc.C400331200CrossRef
30.
Nateri AS, Spencer-Dene B, Behrens A: Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature. 2005, 437: 281-285. 10.1038/nature03914CrossRef
31.
Habas R, Dawid IB, He X: Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. Genes & development. 2003, 17: 295-309. 10.1101/gad.1022203CrossRef
32.
Kawasaki Y, Sato R, Akiyama T: Mutated APC and Asef are involved in the migration of colorectal tumour cells. Nature cell biology. 2003, 5: 211-215. 10.1038/ncb937CrossRef
33.
Kawasaki Y, Senda T, Ishidate T, Koyama R, Morishita T, Iwayama Y, Higuchi O, Akiyama T: Asef, a link between the tumor suppressor APC and G-protein signaling. Science. 2000, 289 (5482): 1194-1197. 10.1126/science.289.5482.1194CrossRef
34.
Esufali S, Bapat B: Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation. Oncogene. 2004, 23: 8260-8271. 10.1038/sj.onc.1208007CrossRef
35.
Sansom OJ, Reed KR, Hayes AJ, Ireland H, Brinkmann H, Newton IP, Batlle E, Simon-Assmann P, Clevers H, Nathke IS: Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes & development. 2004, 18: 1385-1390. 10.1101/gad.287404CrossRef
36.
Ahmed NN, Grimes HL, Bellacosa A, Chan TO, Tsichlis PN: Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proceedings of the National Academy of Sciences of the United States of America. 1997, 94: 3627-3632. 10.1073/pnas.94.8.3627PubMedCentralCrossRef
37.
Arcinas M, Heckman CA, Mehew JW, Boxer LM: Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma. Cancer research. 2001, 61: 5202-5206.
38.
Barre B, Avril S, Coqueret O: Opposite regulation of myc and p21waf1 transcription by STAT3 proteins. The Journal of biological chemistry. 2003, 278: 2990-2996. 10.1074/jbc.M210422200CrossRef
39.
Michiels F, Habets GG, Stam JC, Kammen van der RA, Collard JG: A role for Rac in Tiam1-induced membrane ruffling and invasion. Nature. 1995, 375: 338-340. 10.1038/375338a0CrossRef
40.
Otsuki Y, Tanaka M, Kamo T, Kitanaka C, Kuchino Y, Sugimura H: Guanine nucleotide exchange factor, Tiam1, directly binds to c-Myc and interferes with c-Myc-mediated apoptosis in rat-1 fibroblasts. The Journal of biological chemistry. 2003, 278: 5132-5140. 10.1074/jbc.M206733200CrossRef
41.
Sansom OJ, Reed KR, Wetering van de M, Muncan V, Winton DJ, Clevers H, Clarke AR: Cyclin D1 is not an immediate target of beta-catenin following Apc loss in the intestine. The Journal of biological chemistry. 2005, 280: 28463-28467. 10.1074/jbc.M500191200CrossRef
42.
Wang S, Jones KA: CK2 controls the recruitment of Wnt regulators to target genes in vivo. Curr Biol. 2006, 16: 2239-2244. 10.1016/j.cub.2006.09.034CrossRef
43.
Kino T, Souvatzoglou E, Charmandari E, Ichijo T, Driggers P, Mayers C, Alatsatianos A, Manoli I, Westphal H, Chrousos GP, Segars JH: Rho family Guanine nucleotide exchange factor Brx couples extracellular signals to the glucocorticoid signaling system. The Journal of biological chemistry. 2006, 281: 9118-9126. 10.1074/jbc.M509339200PubMedCentralCrossRef
44.
Kawashima T, Bao YC, Nomura Y, Moon Y, Tonozuka Y, Minoshima Y, Hatori T, Tsuchiya A, Kiyono M, Nosaka T: Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factors. The Journal of cell biology. 2006, 175: 937-946. 10.1083/jcb.200604073PubMedCentralCrossRef
45.
Lanning CC, Ruiz-Velasco R, Williams CL: Novel mechanism of the co-regulation of nuclear transport of SmgGDS and Rac1. The Journal of biological chemistry. 2003, 278: 12495-12506. 10.1074/jbc.M211286200CrossRef
46.
Avots A, Buttmann M, Chuvpilo S, Escher C, Smola U, Bannister AJ, Rapp UR, Kouzarides T, Serfling E: CBP/p300 integrates Raf/Rac-signaling pathways in the transcriptional induction of NF-ATc during T cell activation. Immunity. 1999, 10: 515-524. 10.1016/S1074-7613(00)80051-5CrossRef
47.
Singh RR, Song C, Yang Z, Kumar R: Nuclear localization and chromatin targets of p21-activated kinase 1. The Journal of biological chemistry. 2005, 280: 18130-18137. 10.1074/jbc.M412607200CrossRef
48.
Carter JH, Douglass LE, Deddens JA, Colligan BM, Bhatt TR, Pemberton JO, Konicek S, Hom J, Marshall M, Graff JR: Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clin Cancer Res. 2004, 10: 3448-3456. 10.1158/1078-0432.CCR-03-0210CrossRef
49.
Esufali S, Charames GS, Pethe VV, Buongiorno P, Bapat B: Activation of tumor-specific splice variant Rac1b by dishevelled promotes canonical Wnt signaling and decreased adhesion of colorectal cancer cells. Cancer research. 2007, 67: 2469-2479. 10.1158/0008-5472.CAN-06-2843CrossRef
Metadata
Title
Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wnt-responsive promoters to enhance beta-catenin/TCF-dependent transcription in colorectal cancer cells
Authors
Pinella Buongiorno
Vaijayanti V Pethe
George S Charames
Susmita Esufali
Bharati Bapat
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2008
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-7-73

Other articles of this Issue 1/2008

Molecular Cancer 1/2008 Go to the issue

Research

Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity

Research

Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK

Research

Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide

Research

DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein

Research

Down-regulation of transforming growth factor-β type II receptor (TGF-βRII) protein and mRNA expression in cervical cancer

Research

Lymphangiogenesis and lymph node metastasis in breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits